Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Patients and data tracking

- PMLiVE

Cancer Drugs Fund adds Roche, Celgene and Exelixis drugs

Avastin, Abraxane and Cometriq will be funded in certain indications

National Institute for Health and Care Excellence NICE logo

Mixed cancer news from NICE

Agency backs Janssen’s myeloma drug but denies Bayer’s Xofigo in prostate cancer

- PMLiVE

Why we must protect future innovation opportunities

Ahead of the ABPI's annual conference on 10 April, CEO Stephen Whitehead looks at securing a future for innovative medicines

- PMLiVE

Cleaning up pharma’s supply chain

For a clean bill of health companies must address their supply chain risks

- PMLiVE

Double win for J&J’s schizophrenia franchise

Pharma company wins appeal against $1.2bn fine and Risperdal follow-up proves itself in trial

- PMLiVE

Drug-device convergence

Technological advances herald a major oportunity

EU flag

Bergstrom: Europe must collaborate on medicines value

EFPIA chief says national HTA bodies need to have shared process to assess value of new treatments

AstraZeneca to develop mHealth cardiovascular services

Willwork with Vodafone in a new global partnership

- PMLiVE

Life sciences sector ‘aggressively embracing’ new technology

Technology-driven approaches drive breakthroughs, says a new study

- PMLiVE

Meeta Gulyani leaves Roche for Merck Serono

She joins as head of strategy and global franchises

- PMLiVE

Pharma needs to be “revered by society”

Janssen’s Jane Griffiths and EFPIA chief Richard Bergstrom speak at eyeforpharma conference

- PMLiVE

GSK’s cancer vaccine flunks another trial

MAGE-A3 fails to improve survival in lung cancer patients

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links